Related Experiment Videos
Retinoblastoma gene deletions in human glioblastomas
D J Venter1, K L Bevan, R L Ludwig
1Ludwig Institute for Cancer Research, London, UK.
Abstract:
The retinoblastoma susceptibility gene, RB, is the best characterised of the tumour suppressor genes, or 'anti-oncogenes'. Abnormal function of the RB protein is thought to result in loss of an inhibitory effect on cell growth, and thus contribute towards the development of certain human cancers. One group of human cancers of particular interest in relationship to retinoblastoma gene function are the gliomas, which are central nervous system tumours thought to originate from the neuroectoderm, the embryological tissue which also gives rise to retinoblastomas. We have therefore examined a group of benign and malignant gliomas for evidence of structural alterations of the RB gene. Four out of nine (44%) glioblastomas, the most malignant gliomas, showed loss of heterozygosity of a locus within this gene. In addition, one of these hemizygous tumours showed deletion of part of the RB protein-coding region, and this abnormality was also present in cells cultured from the tumour. These findings suggest that RB gene abnormalities may contribute to the development of glioblastomas.
Insights
Tumor suppressor gene RB abnormalities are linked to glioblastomas, a type of brain cancer. Researchers found structural changes in the RB gene in 44% of glioblastoma samples, suggesting its role in tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The retinoblastoma susceptibility gene (RB) is a key tumor suppressor gene.
- Abnormal RB protein function can lead to uncontrolled cell growth, contributing to cancer development.
- Gliomas, a type of central nervous system tumor, are of particular interest due to their shared embryological origin with retinoblastomas.
Purpose of the Study:
- To investigate structural alterations of the RB gene in benign and malignant gliomas.
- To determine the potential role of RB gene abnormalities in the development of glioblastomas.
Main Methods:
- Analysis of RB gene structure in glioma samples.
- Detection of loss of heterozygosity and deletions within the RB gene locus.
- Culturing tumor cells to confirm genetic abnormalities.
Main Results:
- Loss of heterozygosity at an RB gene locus was observed in 4 out of 9 (44%) glioblastomas.
- One glioblastoma with hemizygosity also showed deletion of a portion of the RB protein-coding region.
- This deletion was confirmed in cultured tumor cells.
Conclusions:
- RB gene abnormalities, including deletions, are present in a significant proportion of glioblastomas.
- These findings suggest that alterations in the RB gene may play a role in the pathogenesis of glioblastomas.